Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 239

Similar articles for PubMed (Select 22967381)

1.

[The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].

Li GP, Yang J, Hao J, Yang YM, Ren YN, Xie RF, Fan HH, Qian KC.

Zhonghua Xue Ye Xue Za Zhi. 2012 Jun;33(6):461-6. Chinese.

2.
3.
4.

[Transforming growth factor beta alleviates acute graft-versus-host-disease after allogeneic bone marrow transplantation in murine model].

Wang YN, Feng CC, Liu JL, Li F, Fu L, Wang Z.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008 Oct;16(5):1135-9. Chinese.

PMID:
18928612
5.

[Study of reducing graft-versus-host disease by in vitro blockade of CD40-CD40 ligand co-stimulatory pathway in allogeneic bone marrow transplantation mouse model].

Huang SL, Chen C, Duan LN, Li HW, Wen GM, Li L, Zhan MY, Wei J.

Zhonghua Xue Ye Xue Za Zhi. 2003 Jun;24(6):290-4. Chinese.

PMID:
12859863
6.

Adoptive therapy by transfusing expanded donor murine natural killer T cells can suppress acute graft-versus-host disease in allogeneic bone marrow transplantation.

Yang J, Gao L, Liu Y, Ren Y, Xie R, Fan H, Qian K.

Transfusion. 2010 Feb;50(2):407-17. doi: 10.1111/j.1537-2995.2009.02395.x. Epub 2009 Sep 24.

PMID:
19788510
7.

[Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].

Cao J, Li L, Chen C, Zeng LY, Li ZY, Pan XY, Xu KL.

Zhonghua Xue Ye Xue Za Zhi. 2011 Feb;32(2):83-8. Chinese.

8.

Rapid lethality of hosts by interleukin-12 following H-2 compatible allogeneic bone marrow transplantation: Reminiscence of gut-associated acute graft-versus-host reaction.

Schmitt M, Taniguchi M, Yoshida T, Miyahara Y, Gu X, Mukai K, Yagita H, Dohner H, Shiku H.

Int J Oncol. 2002 Oct;21(4):795-801.

PMID:
12239618
9.
10.

Donor CD4+ T-cell production of tumor necrosis factor alpha significantly contributes to the early proinflammatory events of graft-versus-host disease.

Ewing P, Miklos S, Olkiewicz KM, Müller G, Andreesen R, Holler E, Cooke KR, Hildebrandt GC.

Exp Hematol. 2007 Jan;35(1):155-63.

PMID:
17198884
11.

A mouse model of adoptive immunotherapeutic targeting of autoimmune arthritis using allo-tolerogenic dendritic cells.

Yang J, Yang Y, Ren Y, Xie R, Zou H, Fan H.

PLoS One. 2013 Oct 24;8(10):e77729. doi: 10.1371/journal.pone.0077729. eCollection 2013.

12.

[Effects of immature dendritic cells to express CCR7 on graft-versus-host disease in allogeneic bone marrow transplant mouse model].

Li DP, Wu JQ, Huang YH, Song LX, Gu HH, Gao CL, Li ZY, Pan XY, Xu KL.

Zhonghua Xue Ye Xue Za Zhi. 2013 Sep;34(9):782-7. doi: 10.3760/cma.j.issn.0253-2727.2013.09.010. Chinese.

13.
14.

Prevention of murine acute graft-versus-host disease by recipient-derived TGFbeta1-treated dendritic cells.

Mou HB, Lin MF, Cen H, Huang H, Cai Z.

Transplant Proc. 2004 Jun;36(5):1604-6.

PMID:
15251394
15.

IL-11 separates graft-versus-leukemia effects from graft-versus-host disease after bone marrow transplantation.

Teshima T, Hill GR, Pan L, Brinson YS, van den Brink MR, Cooke KR, Ferrara JL.

J Clin Invest. 1999 Aug;104(3):317-25.

16.

Tryptophan metabolite analog, N-(3,4-dimethoxycinnamonyl) anthranilic acid, ameliorates acute graft-versus-host disease through regulating T cell proliferation and polarization.

Xu J, Wei J, Huang M, Zhu X, Guan J, Yin J, Xiao Y, Zhang Y.

Int Immunopharmacol. 2013 Nov;17(3):601-7. doi: 10.1016/j.intimp.2013.08.004. Epub 2013 Aug 28.

PMID:
23993943
17.
19.

Donor pretreatment with progenipoietin-1 is superior to granulocyte colony-stimulating factor in preventing graft-versus-host disease after allogeneic stem cell transplantation.

MacDonald KP, Rowe V, Filippich C, Thomas R, Clouston AD, Welply JK, Hart DN, Ferrara JL, Hill GR.

Blood. 2003 Mar 1;101(5):2033-42. Epub 2002 Oct 17.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk